January 8, 2008 — A new meningitis vaccine may be better able to produce immunity in infants than the current meningococcal tetravalent glycoconjugate vaccine, according to the results of a ...

The vaccine for the ACWY serogroups is also recommended for adolescents between the ages of 11 and 14, with a booster up to the age of 24, Public Health France said.